IVISense Fluorescent Imaging Panels

Detect drug induced liver injury (DILI) early in the drug discovery process with 爱游戏平台注册登录 's IVISense^™ Toxicology Fluorescent Imaging Panel.

Drug-induced liver injury (DILI) is the leading reason for termination of drug discovery research projects and is a significant concern in attrition of new drug molecules reaching phase III clinical trials. DILI can manifest in hepatocellular, cholestatic, and steatotic forms differing in the type and pattern of tissue injury, biomarker expression and inflammation in the liver lobules.

For research use only. Not for use in diagnostic procedures.

Advance your understanding of cancer using IVISense^™ Tumor Metabolism Fluorescent Imaging Panel specific for measuring and detecting tumor metabolism in vivo.

For research use only. Not for use in diagnostic procedures.

This panel of fluorescent imaging probes detects cellular and molecular players in vascular pathology, enabling non-invasive in vivo characterization of biological changes associated with disease progression or treatment efficacy.

For research use only. Not for use in diagnostic procedures.

Our IVISense^™ Inflammation fluorescent imaging panel enables in vivo visualization and quantification of inflammation biology. The ability to non-invasively quantify inflammation biology in vivo offers greater opportunity for longitudinal studies necessary to better understand disease pathogenesis in the context of intact animal physiology.

For research use only. Not for use in diagnostic procedures.

Get the flexibility you need with our IVISense^™ Featured Probes Pack Fluorescent Imaigng Panel. This panel features a wide range of fluorescent probes specific to various disease areas as well as a fluorescent labeling kit to tag your own proteins, peptides or antibodies.

For research use only. Not for use in diagnostic procedures.

The development of novel and safer cancer therapeutics that target specific molecular targets and broader disease-related processes is crucial to combating this disease. in vivo preclinical imaging systems along with fluorescent probes can help researchers understand complex biological processes related to cancer, validate potential molecular targets, and assess therapeutic response in a whole animal model, non-invasively, longitudinally, and in real-time.

Our IVISense Oncology fluorescent panel contains six carefully selected fluorescent probes that enable researchers to visualize and quantify various tumor-related biological processes to better understand the disease as well as aid in the development of new cancer therapies.

For research use only. Not for use in diagnostic procedures.

Standard methods to assess arthritis in animal models typically involve external measurements of limbs such as paw volume, paw thickness, and redness. While these methods determine the overall progression of disease, they do not access the underlying biology associated with the visible effects of the disease. Since arthritis involves not only inflammation pathways but also changes in vasculature and bone morphology, using fluorescent agents that measure each of these changes individually allow for a more complete assessment of the overall clinical pathology.

爱游戏平台注册登录 's IVISense Arthritis fluorescent panel contains a carefully selected, pre-validated bundle of probes designed for researchers to gain a better understanding of arthritis disease and its progression.

For research use only. Not for use in diagnostic procedures.

Not sure what reagents or probes work best for your in vivo imaging research studies? Try our IVISense^™ Sample Pack which contains our most popular fluorescent probes and IVISbrite^™ D-Luciferin Bioluminescent Substrate in RediJect^™ Solution (XenoLIght^™).

For research use only. Not for use in diagnostic procedures.